| HIV Infection |
1 |
1 |
| Transplantation |
0 |
0.99 |
| Cord Blood |
0 |
0.68 |
| Patient Safety |
0 |
0.66 |
| Cell Transplantation |
0 |
0.55 |
| Stem Cell Research and Therapy |
0 |
0.55 |
| Bone Marrow Transplant |
0 |
0.51 |
| Blood |
0 |
0.46 |
| Biologic Therapy |
0 |
0.41 |
| Anaphylaxis |
0 |
0.34 |
| Graft Versus Host Disease and Transplant Complications |
0 |
0.33 |
| Cancer |
0 |
0.18 |
| CD4 |
0 |
0.18 |
| Viral Load |
0 |
0.18 |
| Child |
0 |
0.14 |
| Genomic Medicine |
0 |
0.14 |
| Bone Marrow |
0 |
0.13 |
| Umbilical Cord |
0 |
0.13 |
| Graft Versus Host Disease |
0 |
0.1 |
| Bone |
0 |
0.09 |
| Graft |
0 |
0.09 |
| Leukemia |
0 |
0.09 |
| LGBT |
0 |
0.09 |
| New York |
0 |
0.09 |
| T-Lymphocyte |
0 |
0.09 |
| Umbilical |
0 |
0.09 |
| CRISPR |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.07 |
| Chronic Kidney Disease |
0 |
0.06 |
| Renal Failure |
0 |
0.06 |
| Adverse Effects |
0 |
0.05 |
| AIDS |
0 |
0.05 |
| Allergy |
0 |
0.05 |
| California |
0 |
0.05 |
| Dorsum |
0 |
0.05 |
| End-Stage Renal Disease |
0 |
0.05 |
| Genetics |
0 |
0.05 |
| HIV Diagnosis |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Immunopathogenesis |
0 |
0.05 |
| Kidney |
0 |
0.05 |
| Match |
0 |
0.05 |
| Opportunistic Infection |
0 |
0.05 |
| Pennsylvania |
0 |
0.05 |
| Prisons |
0 |
0.05 |
| Prophylaxis |
0 |
0.05 |
| Receptors |
0 |
0.05 |
| Remission |
0 |
0.05 |
| Tissue |
0 |
0.05 |
| Medical Life |
0 |
0.03 |